These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6743337

  • 21. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P, Grifantini M.
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [Abstract] [Full Text] [Related]

  • 22. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid.
    Weber G, Yamaji Y, Nagai M, Natsumeda Y, Jayaram HN, Zhen WN, Paulik E.
    Adv Enzyme Regul; 1990 Jul; 30():35-45. PubMed ID: 2206022
    [Abstract] [Full Text] [Related]

  • 23. Amplification of signal transduction capacity and down-regulation by drugs.
    Weber G, Shen F, Yang H, Prajda N, Li W.
    Adv Enzyme Regul; 1999 Jul; 39():51-66. PubMed ID: 10470366
    [Abstract] [Full Text] [Related]

  • 24. Correlation between growth rate and cytochemistry in Morris hepatomas.
    Kang YH, Morris HP, Criss WE.
    Anat Rec; 1982 Feb; 202(2):209-19. PubMed ID: 6278986
    [Abstract] [Full Text] [Related]

  • 25. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN, Ahluwalia GS, Jayaram HN, Cooney DA, Johns DG.
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [Abstract] [Full Text] [Related]

  • 26. Cytoprotective features of selenazofurin in hematopoietic cells.
    Pogrebniak A, Hasmann M, Schemainda I, Pelka-Fleischer R, Nuessler V.
    Int J Clin Pharmacol Ther; 2002 Aug; 40(8):368-75. PubMed ID: 12467305
    [Abstract] [Full Text] [Related]

  • 27. Rat hepatomas: chemotherapy with lycurim and pyrazofurin.
    Lui MS, Jackson RC, Harkrader RJ, Weber G.
    J Natl Cancer Inst; 1982 Apr; 68(4):665-8. PubMed ID: 6951080
    [Abstract] [Full Text] [Related]

  • 28. Tiazofurin: a new antitumor agent.
    O'Dwyer PJ, Shoemaker DD, Jayaram HN, Johns DG, Cooney DA, Marsoni S, Malspeis L, Plowman J, Davignon JP, Davis RD.
    Invest New Drugs; 1984 Apr; 2(1):79-84. PubMed ID: 6381381
    [Abstract] [Full Text] [Related]

  • 29. Unique bioactivation of tiazofurin--studies with resistant cells.
    Kuttan R.
    Indian J Biochem Biophys; 1989 Jun; 26(3):160-5. PubMed ID: 2620910
    [Abstract] [Full Text] [Related]

  • 30. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA, Sartorelli AC.
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD, O'Dwyer PJ, Trader MW.
    Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
    [Abstract] [Full Text] [Related]

  • 32. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
    Yamada Y, Goto H, Yoshino M, Ogasawara N.
    Biochim Biophys Acta; 1990 Mar 09; 1051(3):209-14. PubMed ID: 1968764
    [Abstract] [Full Text] [Related]

  • 33. Selective sensitivity to tiazofurin of human leukemic cells.
    Jayaram HN, Pillwein K, Nichols CR, Hoffman R, Weber G.
    Biochem Pharmacol; 1986 Jun 15; 35(12):2029-32. PubMed ID: 3718544
    [Abstract] [Full Text] [Related]

  • 34. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM, Miyazaki K, Takeyama H, Sherman ML, Spriggs DR, Carney WP, Kufe DW.
    Cancer Commun; 1989 Jun 15; 1(3):191-7. PubMed ID: 2639729
    [Abstract] [Full Text] [Related]

  • 35. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ, Pawlak K, Nguyen BT, Robins RK, Sadée W.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [Abstract] [Full Text] [Related]

  • 36. Calcium transport and translocation of adenine nucleotides in mitochondria from Morris hepatoma 3924A.
    Eboli ML, Malmström K, Galeotti T, López-Alarcón L, Carafoli E.
    Cancer Res; 1979 Jul 15; 39(7 Pt 1):2737-42. PubMed ID: 445477
    [Abstract] [Full Text] [Related]

  • 37. The effect of varying the time between irradiation and cyclophosphamide on growth response of hepatoma 3924A.
    Hopkins HA, Ritenour ER, MacLeod MS, Looney WB.
    Int J Radiat Oncol Biol Phys; 1979 Sep 15; 5(9):1455-9. PubMed ID: 536255
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Action of lycurim and pyrazofurin on hepatoma 3924A cells in culture.
    Ban J, Olah E, Werber G.
    Cancer Treat Rep; 1982 Feb 15; 66(2):343-9. PubMed ID: 6895716
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.